Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- New TLO to Promote Technology Transfer from Korosho-controlled Institutes
January 27, 2003
- Smiths Medical Japan: New Small Pulse Oximeter
January 27, 2003
- Fujisawa, Sankyo to Codevelop Oral Azole Antifungal Agent
January 27, 2003
- Drug Industry Invested \810.9 Bil., Up 8.7%, in Research in FY2001
January 27, 2003
- JACR Drafts New GL for "Equipment Lease System Sales"
January 27, 2003
- FDA Requires More Time for Review of Iressa: AstraZeneca
January 27, 2003
- REGULATORY NEWS IN BRIEF
January 27, 2003
- IATRON: IMMULYZE 1000 Immunochemoluminescence System
January 27, 2003
- Ono Licenses CCR5 Antagonists to GSK
January 27, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
January 27, 2003
- DIAGNOSTIC NEWS IN BRIEF
January 27, 2003
- Sales of Risperdal Going Well
January 27, 2003
- Takeda, Beth Israel Deaconess Medical Center to Collaborate on Metabolic Disease Research
January 27, 2003
- Dipyridamole Shows Lowest Bleeding Risk in Secondary Stroke Prevention
January 27, 2003
- Sales of Cancer Analgesic Durotep Patch Rising Fast: Janssen, Kyowa Hakko
January 27, 2003
- Takara Bio Strengthens Collaboration with Lynx Therapeutics
January 27, 2003
- Boehringer Ingelheim to Codevelop Anticancer Agents with Sagres Discovery
January 27, 2003
- GE Makers Must Be Self-reliant: EPMA President Sugiura
January 27, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
January 27, 2003
- Chugai, GSK, Novartis to Enhance Supply of Drugs for Influenza
January 27, 2003
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…